201 related articles for article (PubMed ID: 37369493)
1. The Impact of the COVID-19 Pandemic on Breast and Cervical Cancer Screening: A Systematic Review.
Elemes S; Stachteas P; Haidich AB; Mamopoulos A; Smyrnakis E
In Vivo; 2023; 37(4):1455-1476. PubMed ID: 37369493
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. [Health technology assessment report: Computer-assisted Pap test for cervical cancer screening].
Della Palma P; Moresco L; Giorgi Rossi P
Epidemiol Prev; 2012; 36(5 Suppl 3):e1-43. PubMed ID: 23139174
[TBL] [Abstract][Full Text] [Related]
4. The Short-Term Impact Of COVID-19 Pandemic on Cervical Cancer Screening: A Systematic Review and Meta-Analysis.
Sasidharanpillai S; Ravishankar N
Asian Pac J Cancer Prev; 2022 May; 23(5):1497-1504. PubMed ID: 35633530
[TBL] [Abstract][Full Text] [Related]
5. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
[TBL] [Abstract][Full Text] [Related]
6. Global Association of COVID-19 Pandemic Measures With Cancer Screening: A Systematic Review and Meta-analysis.
Teglia F; Angelini M; Astolfi L; Casolari G; Boffetta P
JAMA Oncol; 2022 Sep; 8(9):1287-1293. PubMed ID: 35797056
[TBL] [Abstract][Full Text] [Related]
7. Impact of COVID-19 pandemic on breast and cervical cancer screening in Denmark: A register-based study.
Nonboe MH; Napolitano G; Schroll JB; Vejborg I; Waldstrøm M; Lynge E
Elife; 2023 Mar; 12():. PubMed ID: 36943035
[TBL] [Abstract][Full Text] [Related]
8. Impact of COVID-19 in Cervical and Breast Cancer Screening and Systemic Treatment in São Paulo, Brazil: An Interrupted Time Series Analysis.
Duarte MBO; Argenton JLP; Carvalheira JBC
JCO Glob Oncol; 2022 Jun; 8():e2100371. PubMed ID: 35696624
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 and inequities in colorectal and cervical cancer screening and diagnosis in Washington State.
Amram O; Amiri S; Robison J; Pflugeisen CM; Monsivais P
Cancer Med; 2022 Aug; 11(15):2990-2998. PubMed ID: 35304835
[TBL] [Abstract][Full Text] [Related]
10. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
11. Examining the perceived impact of the COVID-19 pandemic on cervical cancer screening practices among clinicians practicing in Federally Qualified Health Centers: A mixed methods study.
Fuzzell L; Lake P; Brownstein NC; Fontenot HB; Whitmer A; Michel A; McIntyre M; Rossi SL; Kajtezovic S; Vadaparampil ST; Perkins R
Elife; 2023 Sep; 12():. PubMed ID: 37664989
[TBL] [Abstract][Full Text] [Related]
12. Prevention, diagnosis and treatment of cervical cancer: A systematic review of the impact of COVID-19 on patient care.
Ferrara P; Dallagiacoma G; Alberti F; Gentile L; Bertuccio P; Odone A
Prev Med; 2022 Nov; 164():107264. PubMed ID: 36150446
[TBL] [Abstract][Full Text] [Related]
13. Concordance of Anyplex™ II HPV HR assays with reference HPV assays in cervical cancer screening: Systematic review.
Biazin H
J Virol Methods; 2022 Mar; 301():114435. PubMed ID: 34919974
[TBL] [Abstract][Full Text] [Related]
14. Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and meta-analysis.
Musa J; Achenbach CJ; O'Dwyer LC; Evans CT; McHugh M; Hou L; Simon MA; Murphy RL; Jordan N
PLoS One; 2017; 12(9):e0183924. PubMed ID: 28873092
[TBL] [Abstract][Full Text] [Related]
15. Japanese cancer screening programs during the COVID-19 pandemic: Changes in participation between 2017-2020.
Machii R; Takahashi H
Cancer Epidemiol; 2023 Feb; 82():102313. PubMed ID: 36508964
[TBL] [Abstract][Full Text] [Related]
16. Level of awareness of cervical and breast cancer risk factors and safe practices among college teachers of different states in india: do awareness programmes have an impact on adoption of safe practices?
Shankar A; Rath G; Roy S; Malik A; Bhandari R; Kishor K; Barnwal K; Upadyaya S; Srivastava V; Singh R
Asian Pac J Cancer Prev; 2015; 16(3):927-32. PubMed ID: 25735384
[TBL] [Abstract][Full Text] [Related]
17. Geographic Examination of COVID-19 Test Percent Positivity and Proportional Change in Cancer Screening Volume, National Breast and Cervical Cancer Early Detection Program.
Bermudez Y; Scott LC; Beckman M; DeGroff A; Kenney K; Sun J; Rockwell T; Helsel W; Kammerer W; Sheu A; Miller J; Richardson LC
Prev Chronic Dis; 2022 Sep; 19():E59. PubMed ID: 36108291
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of the impact of the COVID-19 pandemic on breast cancer screening and diagnosis.
Li T; Nickel B; Ngo P; McFadden K; Brennan M; Marinovich ML; Houssami N
Breast; 2023 Feb; 67():78-88. PubMed ID: 36646004
[TBL] [Abstract][Full Text] [Related]
19. Association between comorbidity and participation in breast and cervical cancer screening: A systematic review and meta-analysis.
Diaz A; Kang J; Moore SP; Baade P; Langbecker D; Condon JR; Valery PC
Cancer Epidemiol; 2017 Apr; 47():7-19. PubMed ID: 28086199
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]